Live Breaking News & Updates on Krys Cerisier|Page 8

Stay updated with breaking news from Krys cerisier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $148.00 at Chardan Capital

Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price upped by Chardan Capital from $133.00 to $148.00 in a research note issued to investors on Monday morning, The Fly reports. Other equities analysts have also recently issued research reports about the stock. William Blair reaffirmed an outperform rating on shares of Krystal Biotech in […] ....

United States , Stifel Nicolaus , Daniel Janney , William Blair , Dinoa Rossi , Great West Life Assurance Co , Tower Research Capital , Almanack Investment Partners , Goldman Sachs Group , Krystal Biotech Inc , Allspring Global Investments Holdings , Cubist Systematic Strategies , Krystal Biotech , Get Rating , Chardan Capital , Biotech Stock Down , Director Daniel Janney , Director Dino , Investment Partners , Global Investments Holdings , West Life Assurance , Research Capital , Krystal Biotech Daily , Nasdaq Krys , Boost Price Target ,

Research Analysts Set Expectations for Krystal Biotech, Inc.'s FY2027 Earnings (NASDAQ:KRYS)

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) – Research analysts at William Blair boosted their FY2027 earnings per share estimates for shares of Krystal Biotech in a research report issued to clients and investors on Monday, May 22nd. William Blair analyst T. Lugo now expects that the company will post earnings per share of $8.76 […] ....

United States , Kathryn Romano , William Blair , Dinoa Rossi , Krystal Biotech Inc , Group Plc , Goldman Sachs Group , Manufacturers Life Insurance Company , Securities Exchange Commission , Krystal Biotech Company Profile , Allspring Global Investments Holdings , Proshare Advisors , Krystal Biotech , Get Rating , Global Investments Holdings , State Retirement System , General Group Plc , Share Advisors , Exchange Commission , Director Dino , Krystal Biotech Daily , Nasdaq Krys , Earnings Estimates ,

Guggenheim Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $130.00

Krystal Biotech (NASDAQ:KRYS – Get Rating) had its target price boosted by Guggenheim from $101.00 to $130.00 in a report issued on Monday, The Fly reports. Guggenheim’s price target indicates a potential upside of 9.12% from the stock’s current price. Other equities analysts also recently issued research reports about the stock. Stifel Nicolaus began coverage […] ....

United States , William Blair , Dinoa Rossi , Daniel Janney , Stifel Nicolaus , Almanack Investment Partners , Cubist Systematic Strategies , Allspring Global Investments Holdings , Tower Research Capital , Great West Life Assurance Co , Securities Exchange Commission , Krystal Biotech Inc , Krystal Biotech Company Profile , Goldman Sachs Group , Krystal Biotech , Get Rating , Director Daniel Janney , Exchange Commission , Director Dino , Investment Partners , Research Capital , Global Investments Holdings , West Life Assurance , Krystal Biotech Daily , Nasdaq Krys , Boost Price Target ,

Krystal Biotech, Inc. (NASDAQ:KRYS) Director Daniel Janney Sells 50,000 Shares

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) Director Daniel Janney sold 50,000 shares of Krystal Biotech stock in a transaction on Friday, May 19th. The stock was sold at an average price of $95.02, for a total transaction of $4,751,000.00. Following the sale, the director now directly owns 157,362 shares in the company, valued at […] ....

William Blair , Daniel Janney , Stifel Nicolaus , Cubist Systematic Strategies , Great West Life Assurance Co , Allspring Global Investments Holdings , Tower Research Capital , Krystal Biotech Inc , Goldman Sachs Group , Almanack Investment Partners , Krystal Biotech , Get Rating , Director Daniel Janney , Investment Partners , Global Investments Holdings , West Life Assurance , Research Capital , Krystal Biotech Daily , Nasdaq Krys , Insider Trading , Nsider Trades ,

Krystal Biotech, Inc. (NASDAQ:KRYS) CAO Sells $2,726,000.00 in Stock

Krystal Biotech, Inc. (NASDAQ:KRYS – Get Rating) CAO Kathryn Romano sold 25,000 shares of the business’s stock in a transaction dated Monday, May 22nd. The shares were sold at an average price of $109.04, for a total transaction of $2,726,000.00. Following the transaction, the chief accounting officer now directly owns 12,556 shares of the company’s […] ....

United States , Kathryn Romano , Allspring Global Investments Holdings , Group Plc , Krystal Biotech Company Profile , Proshare Advisors , Goldman Sachs Group , Krystal Biotech Inc , Manufacturers Life Insurance Company , Krystal Biotech , Get Rating , Global Investments Holdings , State Retirement System , General Group Plc , Share Advisors , Krystal Biotech Daily , Nasdaq Krys , Insider Trading , Nsider Trades ,